Lilly is the maker of tirzepatide, a drug sold under the name Mounjaro for type 2 diabetes and as Zepbound for weight loss.

Let's consider one company in each category. The one that could benefit from Anthropic's IPO is Broadcom ( AVGO -5.48%), and ...

The e-commerce company has beaten its own forecast all year. Is a cheaper stock enough to buy ahead of the next one?

Normalized EBITDA margins expanded to more than 33%, giving management room to fund growth and return capital through ...

The Schwab U.S. Dividend Equity ETF has a current yield of 3.1%. To generate the equivalent of $1,000 per month in dividend ...

Record contracted backlog of $1.8 billion at the company's share secures multiyear revenue visibility through 2028.

Structural cost cuts and market share gains in a downturn hint at what AGCO could deliver when farm economics recover.

Automated sorting and higher-margin customer mix are driving margin expansion faster than volume growth, a shift that could ...

In its most recent earnings report, the company forecast an operating margin of 12.5%, though historically that number has ...

The company's net interest margin widened to 3.8% as loan pricing and deposit funding improved, fueling 12% year-over-year ...

Multiyear customer contracts and aggressive buybacks reveal how Sandisk is converting AI-driven demand into shareholder ...

Cost discipline and proprietary technology are building structural advantages that protect long-term profit margins.